Vaxcyte, Inc. PCVX Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s change in lease liabilities?
- Vaxcyte, Inc. (PCVX) reported change in lease liabilities of -$1.29M in Q1 2026.
- How has Vaxcyte, Inc.'s change in lease liabilities changed year-over-year?
- Vaxcyte, Inc.'s change in lease liabilities decreased by 108.0% year-over-year, from $16M to -$1.29M.
- What is the long-term trend for Vaxcyte, Inc.'s change in lease liabilities?
- Over 2 years (2022 to 2024), Vaxcyte, Inc.'s change in lease liabilities has grown at a 503.2% compound annual growth rate (CAGR), from $1.15M to $41.89M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.